The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Detection of clinically-actionable alterations as hallmarks of de novo small cell prostate cancer.
 
Gillian Rae Vandekerkhove
No Relationships to Disclose
 
Edmund Chedgy
No Relationships to Disclose
 
Cameron Herberts
No Relationships to Disclose
 
Matti Annala
No Relationships to Disclose
 
Ladan Fazli
No Relationships to Disclose
 
Himisha Beltran
Consulting or Advisory Role - Abbvie; Genzyme; GlaxoSmithKline; Janssen Oncology
Research Funding - Abbvie/Stemcentrx; Astellas Pharma (Inst); Janssen (Inst); Lilly (Inst); Millennium (Inst)
 
Kim N. Chi
Honoraria - Amgen; Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Lilly/ImClone (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst)
 
Alexander William Wyatt
Consulting or Advisory Role - Genzyme
Speakers' Bureau - Janssen